Global Corticosteroids Market size and share is currently valued at USD 5.96 billion in 2024 and is anticipated to generate an estimated revenue of USD 8.53 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
Corticosteroids are synthetic drugs that closely resemble cortisol, a hormone naturally produced by the adrenal glands. These drugs are primarily used to reduce inflammation and modulate the immune system, which makes them essential in treating a variety of conditions, such as allergies, autoimmune diseases, arthritis, skin conditions, and asthma.
The global corticosteroids market is expected to continue its expansion due to the growing demand for treatments that target chronic inflammatory conditions. Innovations in the form of topical corticosteroids for dermatological conditions and systemic corticosteroids for internal conditions are also contributing to market dynamics. Furthermore, the growing adoption of corticosteroid-based therapies in emerging markets is helping to drive market penetration, especially as access to healthcare improves in developing countries.
Major Key Players:
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca plc
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Limited
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Lupin Limited
- Merck & Co., Inc.
- Novartis International AG
- copyright Inc.
- Sanofi S.A.
???????????????????????????? ???????????? ???????????????????????????????? ???????????????????????????????????????????????????? ???????????????????????? ????????????????:
https://www.polarismarketresearch.com/industry-analysis/corticosteroids-market
Country-Wise Analysis and Market Trends
United States
The United States is the largest and most advanced market for corticosteroids, driven by high healthcare spending and widespread access to advanced medical treatments. The market is characterized by a high demand for anti-inflammatory drugs to treat conditions like asthma, allergies, and arthritis.
In recent years, corticosteroid injections have gained popularity for managing localized conditions such as joint pain and inflammation, offering patients relief without the need for oral medication. Furthermore, systemic corticosteroids are commonly prescribed for autoimmune diseases, while topical corticosteroids remain a go-to solution for dermatological conditions like eczema and psoriasis.
The shift toward biologics in certain therapeutic areas, such as rheumatoid arthritis, has created a competitive landscape, but corticosteroids continue to be widely used due to their effectiveness, cost-efficiency, and rapid onset of action.
European Union
The European Union (EU) represents a significant market for corticosteroids, with demand driven by the increasing incidence of chronic inflammatory diseases and the growing elderly population. In the EU, countries like Germany, France, and the UK are major contributors to market growth, driven by well-established healthcare systems and high levels of healthcare spending.
Topical corticosteroids, in particular, are widely prescribed in the treatment of chronic skin conditions such as dermatitis, eczema, and psoriasis. The corticosteroid injection segment is also experiencing growth, particularly for managing joint pain in older adults suffering from conditions like osteoarthritis. Regulatory authorities in the EU are focused on safety and efficacy, driving innovations that improve the delivery of corticosteroid therapies while minimizing side effects.
In the UK, systemic corticosteroids continue to play a crucial role in the treatment of inflammatory conditions like asthma and rheumatoid arthritis. However, there is increasing interest in minimizing long-term corticosteroid use due to potential side effects, leading to a rise in combination therapies and a shift toward biologics in some disease areas.
India
India is an emerging market for corticosteroids, fueled by a rising burden of chronic diseases, including asthma, allergies, and autoimmune disorders. The market is expected to experience rapid growth, driven by increasing awareness of available treatments and improving healthcare access in urban and rural areas alike.
Topical corticosteroids are commonly used to manage skin conditions, which are prevalent in India due to environmental factors and a high incidence of dermatological disorders. Corticosteroid injections are increasingly being used for managing joint inflammation and pain, particularly in patients suffering from osteoarthritis and other musculoskeletal conditions.
The rise in healthcare infrastructure, coupled with the increasing number of medical professionals recommending corticosteroid treatments, is expected to continue driving market growth. Furthermore, the affordability of corticosteroids compared to biologics ensures their sustained use in treating chronic conditions.
China
China, with its vast population and growing healthcare market, represents one of the fastest-growing regions for corticosteroids. The rising incidence of respiratory diseases like asthma, allergies, and autoimmune disorders has created significant demand for anti-inflammatory drugs.
In China, topical corticosteroids are commonly used for the treatment of eczema, psoriasis, and other dermatological conditions. The country is also experiencing growing use of systemic corticosteroids for inflammatory diseases and corticosteroid injections for conditions like arthritis. With the government’s continued push for healthcare reform and greater access to medical treatments, corticosteroids are becoming more widely available across the country.
As awareness about chronic inflammatory diseases rises, the market for corticosteroids in China is expected to continue its upward trajectory. In addition, the increasing adoption of e-commerce platforms for online drug sales is making corticosteroid medications more accessible to the general population.
Japan
Japan's corticosteroid market is well-established, with a growing demand for both topical corticosteroids and systemic corticosteroids due to the country’s aging population and the increasing incidence of chronic diseases. Skin disorders such as eczema and psoriasis are common in Japan, driving demand for effective corticosteroid-based topical treatments.
In the therapeutic space, corticosteroid injections are widely used in the management of joint pain, particularly in elderly patients suffering from conditions like rheumatoid arthritis and osteoarthritis. The Japanese healthcare system’s focus on high-quality medical care ensures that corticosteroid treatments are both accessible and widely prescribed.
Brazil
In Brazil, the corticosteroid market is expanding rapidly, driven by an increase in chronic inflammatory conditions such as asthma, allergies, and rheumatoid arthritis. The country’s large and diverse population has created a significant market for both topical corticosteroids and systemic corticosteroids.
Corticosteroid injections are widely used in Brazil to manage musculoskeletal pain, particularly in patients with arthritis and other inflammatory conditions. There is also an increasing focus on improving patient adherence to corticosteroid therapies through innovations in drug delivery and formulation.
Australia
Australia’s market for corticosteroids is well-established, with high demand for anti-inflammatory drugs and corticosteroid treatments across various therapeutic areas. The country’s healthcare system is highly advanced, and patients benefit from extensive insurance coverage, making corticosteroid medications widely accessible.
Topical corticosteroids are commonly prescribed for skin conditions like eczema and psoriasis, while systemic corticosteroids are used to treat conditions such as asthma, autoimmune disorders, and inflammatory bowel diseases. In addition, corticosteroid injections are increasingly used for managing joint pain, especially in the elderly population suffering from osteoarthritis.
Conclusion
The global corticosteroids market is experiencing sustained growth driven by the rising prevalence of chronic inflammatory conditions and increasing demand for effective treatments. From topical corticosteroids used for dermatological conditions to systemic corticosteroids for treating autoimmune diseases and corticosteroid injections for localized pain relief, these medications remain crucial in modern healthcare.
As the market continues to evolve, innovations in drug formulations, delivery systems, and combination therapies will drive further expansion. Additionally, the growing accessibility of corticosteroids, especially in emerging markets, is expected to contribute significantly to market growth.
More Trending Latest Reports By Polaris Market Research:
U.S. Non-Automotive Rubber Transmission Belts Market
Tonic Wine Market
E-Commerce Logistics Market
Glass Mat Market
Temperature Modulation Devices Market
High Purity Silica Sand for Solar Cell Market
Craft Soda Market
Buy Now Pay Later Market
Broadcast Equipment Market